Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | VIJAYA Vijaya Diagnostic Centre Limited Pharma · Large | JUBLPHARMA Jubilant Pharmova Limited Pharma · Large | ONESOURCE Onesource Specialty Pharma Limited Pharma · Large | SANOFICONR Sanofi Consumer Healthcare India Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 46 | 26 | 26 | 55 |
| Verdict | FAIR VALUE | OVERVALUED | OVERVALUED | FAIR VALUE |
| Style | Financial Turnaround | OVERVALUED | OVERVALUED | Premium Compounder |
| Piotroski | 8/9 | 8/9 | 7/9 | 8/9 |
| Valuation | 0/30 | 5/30 | 2/30 | 2/30 |
| Growth | 14/25 | 4/25 | 14/25 | 13/25 |
| Quality | 13/20 | 0/20 | 0/20 | 20/20 |
| Balance Sheet | 8/15 | 8/15 | 4/15 | 12/15 |
| Cash Flow | 6/10 | 4/10 | 1/10 | 3/10 |
| Price | ₹1,295 | ₹966.5 | ₹1,712.9 | ₹4,713.3 |
| P/E | 77.50 | 34.90 | 748.00 | 43.00 |
| P/B | 14.06 | 2.15 | 3.35 | 28.26 |
| ROE | 19.70% | 6.55% | 0.45% | 71.60% |
| ROCE | 21.30% | 8.99% | 2.06% | 89.90% |
| Debt / Equity | 0.44 | 0.51 | 0.25 | 0.07 |
| FCF Yield | 0.72% | — | — | 1.68% |
| Dividend Y | 0.15% | 0.52% | — | 1.59% |
| Altman Z | 8.39 | 2.69 | 6.68 | 10.54 |
| Promoter % | 52.51% | 47.67% | 30.48% | 71.27% |
| Mkt Cap (₹Cr) | 13404.00 | 15253.00 | 19919.00 | 10870.00 |
| Graham # | ₹187.55 | ₹500.51 | ₹146.98 | ₹648.66 |
| Fair PE | 42.0 | 3.4 | 42.0 | 45.0 |
| MoS % | -83.4% | -1036.2% | -2104.5% | +6.5% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startVIJAYA116
JUBLPHARMA78
ONESOURCE100
SANOFICONR96